Cell Medica Limited-Product Pipeline Review-2015

Cell Medica Limited-Product Pipeline Review-2015

  • Products Id :- GMDHC06982CDB
  • |
  • Pages: 23
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Cell Medica Limited-Product Pipeline Review-2015


Global Markets Direct's, 'Cell Medica Limited-Product Pipeline Review-2015', provides an overview of the Cell Medica Limited's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Cell Medica Limited's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.


The report provides brief overview of Cell Medica Limited including business description, key information and facts, and its locations and subsidiaries

The report reviews current pipeline of Cell Medica Limited's human therapeutic division and enlists all their major and minor projects

The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones

Special feature on out-licensed and partnered product portfolio

The report summarizes all the dormant and discontinued pipeline projects

Latest company statement

Latest news and deals relating to the Cell Medica Limited's pipeline products

Reasons To Buy

Evaluate Cell Medica Limited's strategic position with total access to detailed information on its product pipeline

Assess the growth potential of Cell Medica Limited in its therapy areas of focus

Identify new drug targets and therapeutic classes in the Cell Medica Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas

Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps

Develop strategic initiatives by understanding the focus areas of Cell Medica Limited and exploit collaboration and partnership opportunities

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Plan mergers and acquisitions effectively by identifying the most promising pipeline of Cell Medica Limited

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Explore the dormant and discontinued projects of Cell Medica Limited and identify potential opportunities in those areas

Avoid Intellectual Property Rights related issues

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 3

Cell Medica Limited Snapshot 4

Cell Medica Limited Overview 4

Key Information 4

Key Facts 4

Cell Medica Limited-Research and Development Overview 5

Key Therapeutic Areas 5

Cell Medica Limited-Pipeline Review 7

Pipeline Products by Stage of Development 7

Pipeline Products-Monotherapy 8

Cell Medica Limited-Pipeline Products Glance 9

Cell Medica Limited-Late Stage Pipeline Products 9

Phase III Products/Combination Treatment Modalities 9

Cell Medica Limited-Clinical Stage Pipeline Products 10

Phase II Products/Combination Treatment Modalities 10

Phase I Products/Combination Treatment Modalities 11

Cell Medica Limited-Drug Profiles 12

Cytovir-CMV 12

Product Description 12

Mechanism of Action 12

R&D Progress 12

CMD-003 14

Product Description 14

Mechanism of Action 14

R&D Progress 14

Cytovir-ADV 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

Cell Medica Limited-Pipeline Analysis 17

Cell Medica Limited-Pipeline Products by Route of Administration 17

Cell Medica Limited-Pipeline Products by Molecule Type 18

Cell Medica Limited-Recent Pipeline Updates 19

Cell Medica Limited-Dormant Projects 20

Cell Medica Limited-Locations And Subsidiaries 21

Head Office 21

Appendix 22

Methodology 22

Coverage 22

Secondary Research 22

Primary Research 22

Expert Panel Validation 22

Contact Us 22

Disclaimer 23

List of Tables

Cell Medica Limited, Key Information 4

Cell Medica Limited, Key Facts 4

Cell Medica Limited-Pipeline by Indication, 2015 6

Cell Medica Limited-Pipeline by Stage of Development, 2015 7

Cell Medica Limited-Monotherapy Products in Pipeline, 2015 8

Cell Medica Limited-Phase III, 2015 9

Cell Medica Limited-Phase II, 2015 10

Cell Medica Limited-Phase I, 2015 11

Cell Medica Limited-Pipeline by Route of Administration, 2015 17

Cell Medica Limited-Pipeline by Molecule Type, 2015 18

Cell Medica Limited-Recent Pipeline Updates, 2015 19

Cell Medica Limited-Dormant Developmental Projects,2015 20

List of Figures

Cell Medica Limited-Pipeline by Top 10 Indication, 2015 6

Cell Medica Limited-Pipeline by Stage of Development, 2015 7

Cell Medica Limited-Monotherapy Products in Pipeline, 2015 8

Cell Medica Limited-Pipeline by Top 10 Route of Administration, 2015 17

Cell Medica Limited-Pipeline by Top 10 Molecule Type, 2015 18

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Current R&D Portfolio of Cell Medica Limited; Cell Medica Limited - Key Therapeutics; Cell Medica Limited - Pipeline Overview and Promising Molecules; Cell Medica Limited - News; Cell Medica Limited - Latest Updates; Cell Medica Limited - Pipeline; Cell Medica Limited - Discontinued/Dormant Projects

select a license
Single User License
USD 1500 INR 109350
Site License
USD 3000 INR 218700
Corporate User License
USD 4500 INR 328050



An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements....

This is with regards to your report on India PVC pipes and fitting market outlook industry outlook to 2019. This is a very well written report and accept my compliments on the same.... ...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com